Metastases to the Pancreas

  • Momin T. SiddiquiEmail author
Part of the Essentials in Cytopathology book series (EICP, volume 28)


Metastasis to the pancreas is rare and not a common occurrence. The primary sites of origin for these metastatic lesions to the pancreas include the kidney, lung, colon, breast, and ovary. In addition, the pancreas can also be involved in metastatic melanomas, malignant lymphomas, and neuroendocrine tumor arising from different primary sources. Even with this diverse group of tumors, renal cell carcinoma and tumors arising from the lung remain the largest groups of tumors which metastasize to the pancreas. Metastatic disease to the pancreas is usually part of widespread and disseminated disease rather than being a solitary presentation. However, it can present as a solitary tumor many years after the primary malignancy was initially diagnosed. Radiographic studies, which primarily include endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), are currently the mainstay to evaluate and diagnose these tumors. EUS-FNA ensures a high degree of safety, is cost-effective, and leads to minimal morbidity in patients. It ensures accuracy in diagnosing metastatic disease to the pancreas, which is extremely important for clinical staging as well as appropriate management.


Pancreas Metastases Renal cell carcinoma Adenocarcinoma Squamous cell carcinoma 


  1. 1.
    Benning TL, Silverman JF, Berns LA, Geisinger KR. Fine needle aspiration of metastatic and hematologic malignancies clinically mimicking pancreatic carcinoma. Acta Cytol. 1992;36:471–6.PubMedGoogle Scholar
  2. 2.
    Carson HJ, Green LK, Castelli MJ, Reyes CV, Prinz RA, Gattuso P. Utilization of fine-needle aspiration biopsy in the diagnosis of metastatic tumors to the pancreas. Diagn Cytopathol. 1995;12:8–13.CrossRefGoogle Scholar
  3. 3.
    Fritscher-Ravens A, Sriram PV, Krause C, et al. Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2001;53:65–70.CrossRefGoogle Scholar
  4. 4.
    Mesa H, Stelow EB, Stanley MW, Mallery S, Lai R, Bardales RH. Diagnosis of non-primary pancreatic neoplasms by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol. 2004;31:313–8.CrossRefGoogle Scholar
  5. 5.
    Volmar KE, Jones CK, Xie HB. Metastases in the pancreas from Non-hematologic neoplasms: report of 20 cases evaluated by fine needle aspiration. Diagn Cytopathol. 2004;31:216–20.CrossRefGoogle Scholar
  6. 6.
    DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61:689–96.CrossRefGoogle Scholar
  7. 7.
    Gilbert CM, Monaco SE, Cooper ST, Khalbuss WE. Endoscopic ultrasound-guided fine-needle aspiration of metastases to the pancreas: a study of 25 cases. Cytojournal. 2011;8:7.CrossRefGoogle Scholar
  8. 8.
    Hijioka S, Matsuo K, Mizuno N, et al. Role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in diagnosing metastasis to the pancreas: a tertiary center experience. Pancreatology. 2011;11:390–8.CrossRefGoogle Scholar
  9. 9.
    Layfield LJ, Hirschowitz SL, Adler DG. Metastatic disease to the pancreas documented by endoscopic ultrasound guided fine-needle aspiration: a seven-year experience. Diagn Cytopathol. 2012;40:228–33.CrossRefGoogle Scholar
  10. 10.
    Ardengh JC, Lopes CV, Kemp R, Venco F, de Lima-Filho ER, dos Santos JS. Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases. BMC Gastroenterol. 2013;13:63.CrossRefGoogle Scholar
  11. 11.
    Atiq M, Bhutani MS, Ross WA, et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas. 2013;42:516–23.CrossRefGoogle Scholar
  12. 12.
    El Hajj II, LeBlanc JK, Sherman S, et al. Endoscopic ultrasound guided biopsy of pancreatic metastases: a large single-center experience. Pancreas. 2013;42:524–30.CrossRefGoogle Scholar
  13. 13.
    Olson MT, Wakely PE Jr, Ali SZ. Metastases to the pancreas diagnosed by fine-needle aspiration. Acta Cytol. 2013;57:473–80.CrossRefGoogle Scholar
  14. 14.
    Waters L, Si Q, Caraway N, Mody D, Staerkel G, Sneige N. Secondary tumors of the pancreas diagnosed by endoscopic ultrasound guided fine-needle aspiration: a 10-year experience. Diagn Cytopathol. 2014;42:738–43.CrossRefGoogle Scholar
  15. 15.
    Smith AL, Odronic SI, Springer BS, Reynolds JP. Solid tumor metastases to the pancreas diagnosed by FNA: a single-institution experience and review of the literature. Cancer Cytopathol. 2015;123:347–55.CrossRefGoogle Scholar
  16. 16.
    Alomari AK, Ustun B, Aslanian HR, Ge X, Chhieng D, Cai G. Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: an institution’s experience. Cytojournal. 2016;13:1.CrossRefGoogle Scholar
  17. 17.
    Raymond SLT, Yugawa D, Chang KHF, Ena B, Tauchi-Nishi PS. Metastatic neoplasms to the pancreas diagnosed by fine needle aspiration/biopsy cytology: a 15-year retrospective analysis. Diagn Cytopathol. 2017;45:771–83.CrossRefGoogle Scholar
  18. 18.
    Hou Y, Rulong S, Tonkovich D, Li Z. Endoscopic ultrasound guided fine needle aspiration diagnosis of secondary tumors involving pancreas: an institution’s experience. J Am Soc Cytopathol. 2018;7:261–7.CrossRefGoogle Scholar
  19. 19.
    Vogt AP, Cohen C, Siddiqui MT. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis. Diagn Cytopathol. 2014;42(5):453–8.CrossRefGoogle Scholar
  20. 20.
    Ko HM, Saieg MA, da Cunha Santos G, Kamel-Reid S, Boerner SL, Geddie WR. Use of cytological samples of metastatic melanoma for ancillary studies. Cytopathology. 2017;28(3):221–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineWeill-Cornell Medicine, New York Presbyterian HosptialNew YorkUSA

Personalised recommendations